BRPI0416006A - composições farmacêuticas com base em um sal de idazoxano ou um dos polimorfos do mesmo - Google Patents
composições farmacêuticas com base em um sal de idazoxano ou um dos polimorfos do mesmoInfo
- Publication number
- BRPI0416006A BRPI0416006A BRPI0416006-1A BRPI0416006A BRPI0416006A BR PI0416006 A BRPI0416006 A BR PI0416006A BR PI0416006 A BRPI0416006 A BR PI0416006A BR PI0416006 A BRPI0416006 A BR PI0416006A
- Authority
- BR
- Brazil
- Prior art keywords
- idazoxan
- salt
- pharmaceutical composition
- neuroleptic
- exhibiting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"COMPOSIçõES FARMACêUTICAS COM BASE EM UM SAL DE IDAZOXANO OU UM DOS POLIMORFOS DO MESMO". Uma composição farmacêutica que compreende idazoxano, um dos derivados do mesmo e os sais farmaceuticamente aceitáveis do mesmo, os racematos do mesmo, os isómeros oticamente ativos do mesmo e os polimorfos do mesmo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0312626A FR2861299B1 (fr) | 2003-10-28 | 2003-10-28 | Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes |
PCT/FR2004/002773 WO2005041956A1 (fr) | 2003-10-28 | 2004-10-28 | Compositions pharmaceutiques a base de sel d’idazoxan ou l’un de ses polymorphes |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0416006A true BRPI0416006A (pt) | 2007-01-02 |
BRPI0416006B1 BRPI0416006B1 (pt) | 2019-02-05 |
Family
ID=34400871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0416006A BRPI0416006B1 (pt) | 2003-10-28 | 2004-10-28 | composições farmacêuticas com base em um sal de idazoxano,comprimidos,processo para fabricação dos mesmos e usos das referidas composições |
Country Status (19)
Country | Link |
---|---|
US (2) | US7338970B2 (pt) |
EP (1) | EP1682124B1 (pt) |
JP (1) | JP5160090B2 (pt) |
CN (2) | CN1870993B (pt) |
AT (1) | ATE381331T1 (pt) |
AU (1) | AU2004285316B2 (pt) |
BR (1) | BRPI0416006B1 (pt) |
CA (1) | CA2542752A1 (pt) |
CY (1) | CY1107304T1 (pt) |
DE (1) | DE602004010837T2 (pt) |
DK (1) | DK1682124T3 (pt) |
ES (1) | ES2297525T3 (pt) |
FR (1) | FR2861299B1 (pt) |
HK (1) | HK1094769A1 (pt) |
HR (1) | HRP20080108T3 (pt) |
MX (1) | MXPA06004717A (pt) |
PL (1) | PL1682124T3 (pt) |
PT (1) | PT1682124E (pt) |
WO (1) | WO2005041956A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8476307B2 (en) * | 2003-10-28 | 2013-07-02 | Pierre Fabre Medicament | Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof |
US8088824B2 (en) * | 2007-08-15 | 2012-01-03 | Reata Pharmaceuticals Inc. | Forms of CDDO methyl ester |
UA102128C2 (en) * | 2008-12-05 | 2013-06-10 | Х. Луннбек А/С | Nalmefene hydrochloride dihydrate |
WO2023159145A1 (en) * | 2022-02-16 | 2023-08-24 | Terran Biosciences, Inc. | Deuterated idazoxan and methods of use thereof |
CN117338772B (zh) * | 2023-11-22 | 2024-04-09 | 徐州医科大学 | 一种药物组合物及其在制备用于预防和/或治疗重性抑郁障碍的药物中的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH16249A (en) * | 1980-02-04 | 1983-08-16 | Reckitt & Colmann Prod Ltd | Imidazoline derivatives,its pharmaceutical composition and method of use |
US4541893A (en) * | 1984-05-15 | 1985-09-17 | Advanced Micro Devices, Inc. | Process for fabricating pedestal interconnections between conductive layers in an integrated circuit |
FR2698789B1 (fr) | 1992-12-07 | 1995-03-03 | Pf Medicament | Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution. |
US5492907A (en) * | 1992-12-09 | 1996-02-20 | The United States Of America As Represented By The Department Of Health & Human Services | Antipsychotic composition and method of treatment |
IT1264517B1 (it) * | 1993-05-31 | 1996-09-24 | Ekita Investments Nv | Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati |
US5574059A (en) * | 1995-10-27 | 1996-11-12 | Cornell Research Foundation, Inc. | Treating disorders mediated by vascular smooth muscle cell proliferation |
FR2746314B1 (fr) | 1996-03-25 | 1998-06-12 | Pf Medicament | Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee |
US6232215B1 (en) * | 1996-09-18 | 2001-05-15 | United Microelectronics Corp. | Method for forming increased density for interconnection metallization |
FR2774811B1 (fr) * | 1998-02-10 | 2003-05-09 | Sgs Thomson Microelectronics | Procede de formation de lignes conductrices sur des circuits integres |
FR2801786B1 (fr) * | 1999-12-01 | 2002-03-01 | Fabre Pierre Cosmetique | Nouvelles compositions topiques a base d'idazoxan et de cafeine ou de ses derives solubles et leur utilisation comme amincissant et/ou dans le traitement de la cellulite |
-
2003
- 2003-10-28 FR FR0312626A patent/FR2861299B1/fr not_active Expired - Fee Related
- 2003-11-28 US US10/722,451 patent/US7338970B2/en not_active Expired - Fee Related
-
2004
- 2004-10-28 DK DK04805330T patent/DK1682124T3/da active
- 2004-10-28 DE DE602004010837T patent/DE602004010837T2/de active Active
- 2004-10-28 AU AU2004285316A patent/AU2004285316B2/en not_active Ceased
- 2004-10-28 AT AT04805330T patent/ATE381331T1/de active
- 2004-10-28 MX MXPA06004717A patent/MXPA06004717A/es active IP Right Grant
- 2004-10-28 EP EP04805330A patent/EP1682124B1/fr active Active
- 2004-10-28 WO PCT/FR2004/002773 patent/WO2005041956A1/fr active IP Right Grant
- 2004-10-28 BR BRPI0416006A patent/BRPI0416006B1/pt not_active IP Right Cessation
- 2004-10-28 PL PL04805330T patent/PL1682124T3/pl unknown
- 2004-10-28 ES ES04805330T patent/ES2297525T3/es active Active
- 2004-10-28 PT PT04805330T patent/PT1682124E/pt unknown
- 2004-10-28 CA CA002542752A patent/CA2542752A1/fr not_active Abandoned
- 2004-10-28 CN CN2004800315006A patent/CN1870993B/zh not_active Expired - Fee Related
- 2004-10-28 JP JP2006537357A patent/JP5160090B2/ja not_active Expired - Fee Related
- 2004-10-28 CN CN2011101941032A patent/CN102349873B/zh not_active Expired - Fee Related
-
2007
- 2007-01-19 HK HK07100684A patent/HK1094769A1/xx not_active IP Right Cessation
-
2008
- 2008-01-17 US US12/015,788 patent/US8124640B2/en not_active Expired - Fee Related
- 2008-03-10 HR HR20080108T patent/HRP20080108T3/xx unknown
- 2008-03-13 CY CY20081100286T patent/CY1107304T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US20050090537A1 (en) | 2005-04-28 |
CY1107304T1 (el) | 2012-11-21 |
CN102349873B (zh) | 2013-09-25 |
US8124640B2 (en) | 2012-02-28 |
DK1682124T3 (da) | 2008-04-28 |
EP1682124A1 (fr) | 2006-07-26 |
CN1870993A (zh) | 2006-11-29 |
EP1682124B1 (fr) | 2007-12-19 |
BRPI0416006B1 (pt) | 2019-02-05 |
WO2005041956A1 (fr) | 2005-05-12 |
ATE381331T1 (de) | 2008-01-15 |
AU2004285316A1 (en) | 2005-05-12 |
DE602004010837T2 (de) | 2008-12-11 |
DE602004010837D1 (de) | 2008-01-31 |
US7338970B2 (en) | 2008-03-04 |
HK1094769A1 (en) | 2007-04-13 |
CA2542752A1 (fr) | 2005-05-12 |
PL1682124T3 (pl) | 2008-05-30 |
US20080113022A1 (en) | 2008-05-15 |
CN1870993B (zh) | 2012-04-04 |
JP5160090B2 (ja) | 2013-03-13 |
CN102349873A (zh) | 2012-02-15 |
JP2007509911A (ja) | 2007-04-19 |
FR2861299A1 (fr) | 2005-04-29 |
PT1682124E (pt) | 2008-03-05 |
FR2861299B1 (fr) | 2006-01-27 |
MXPA06004717A (es) | 2006-07-05 |
AU2004285316B2 (en) | 2010-08-19 |
HRP20080108T3 (en) | 2008-04-30 |
ES2297525T3 (es) | 2008-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhanel et al. | A critical review of the fluoroquinolones: focus on respiratory tract infections | |
US20050233010A1 (en) | Lithium combinations, and uses related thereto | |
FI2498756T4 (fi) | Neratinibimaleaatin tablettiformulaatiot | |
RS52577B (en) | ONE-DAY OXYCODON FORMULATIONS | |
NO20075641L (no) | Kroman og kromenderivater og ders anvendelse | |
MA27703A1 (fr) | Derives de diazepino-indole servant d'inhibiteurs de kinases | |
UA102517C2 (ru) | Замещенные производные морфолина и тиоморфолина, фармацевтическая композиция на их основе и их применение для производства лекарственного средства для лечения расстройства или заболевания центральной нервной системы | |
CA2899455C (en) | Treatments for depression and other diseases with a low dose agent | |
MY134110A (en) | Combinations of reboxetine and neuroleptic agents | |
AU4818000A (en) | Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands | |
AU2001285451A1 (en) | 2,4-substituted pyridine derivatives | |
JP2002520273A5 (pt) | ||
JP2007297405A (ja) | 5−ht1a受容体サブタイプ作動薬 | |
CY1107304T1 (el) | Φαρμακευτικες συνθεσεις με βαση ιδαζοξανη ή μια απο τις πολυμορφικες μορφες της | |
ES2193875A1 (es) | Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos. | |
PE20061318A1 (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de trastornos psicoticos | |
MXPA03000548A (es) | Combinacion novedosa de agonista (5-ht2) y antagonistas (5-ht6) de serotonina como formulacion farmaceutica. | |
CA2507002A1 (en) | Solid drug for oral use | |
HRP20090569T1 (hr) | Stabilni kristalni oblici bifeprunoks mesilata, oblici njihovog doziranja i postupak njihovog korištenja | |
NO20085271L (no) | Muscarin reseptoragonister som er effektive i behandling av smerte, Alzheimers sykdom og schizofreni | |
JPS63258819A (ja) | ドーパミン受容体アゴニストの新規用途 | |
JP2007516193A5 (pt) | ||
EP1784173A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING METABOLIC BONE DISEASES CONTAINING ALPHA-ARYLMETHOXYACRYLATE DERIVATIVES | |
KR20160101012A (ko) | 신규 조성물 | |
Sayyah et al. | Jak2 inhibitors: rationale and role as therapeutic agents in hematologic malignancies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B09X | Republication of the decision to grant [chapter 9.1.3 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/02/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/02/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 16A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2601 DE 10-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |